{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:12:58Z","timestamp":1765609978066,"version":"3.37.3"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T00:00:00Z","timestamp":1574640000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1007\/s00228-019-02790-2","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T19:02:47Z","timestamp":1574708567000},"page":"161-174","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Levetiracetam as preventive treatment in adults with migraine: an up-to-date systematic review and quantitative meta-analysis"],"prefix":"10.1007","volume":"76","author":[{"given":"Georgia","family":"Tsaousi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3781-9680","authenticated-orcid":false,"given":"Chryssa","family":"Pourzitaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon","family":"Siafis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanassios","family":"Kyrgidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios","family":"Grosomanidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitrios","family":"Kouvelas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Georgios","family":"Papazisis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,25]]},"reference":[{"issue":"1","key":"2790_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10194-018-0846-2","volume":"19","author":"TJ Steiner","year":"2018","unstructured":"Steiner TJ, Stovner LJ, Vos T, Jensen R, Katsarava Z (2018) Migraine is first cause of disability in under 50s: will health politicians now take notice? J Headache Pain 19(1):17","journal-title":"J Headache Pain"},{"key":"2790_CR2","unstructured":"IHS (2013) The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia. (1468\u20132982 (Electronic))"},{"key":"2790_CR3","doi-asserted-by":"crossref","unstructured":"Sprenger T, Goadsby PJJBM (2009) Migraine pathogenesis and state of pharmacological treatment options 7(1):71","DOI":"10.1186\/1741-7015-7-71"},{"issue":"7","key":"2790_CR4","doi-asserted-by":"publisher","first-page":"e0130733","DOI":"10.1371\/journal.pone.0130733","volume":"10","author":"JL Jackson","year":"2015","unstructured":"Jackson JL, Cogbill E, Santana-Davila R, Eldredge C, Collier W, Gradall A et al (2015) A Comparative Effectiveness Meta-Analysis of Drugs for the Prophylaxis of Migraine Headache. PLoS One 10(7):e0130733","journal-title":"PLoS One"},{"issue":"3","key":"2790_CR5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/S1474-4422(10)70005-3","volume":"9","author":"PJ Goadsby","year":"2010","unstructured":"Goadsby PJ, Sprenger T (2010) Current practice and future directions in the prevention and acute management of migraine. Lancet Neurol 9(3):285\u2013298","journal-title":"Lancet Neurol"},{"issue":"9","key":"2790_CR6","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1111\/j.1468-1331.2009.02748.x","volume":"16","author":"S Evers","year":"2009","unstructured":"Evers S, Afra J, Frese A, Goadsby PJ, Linde M, May A et al (2009) EFNS guideline on the drug treatment of migraine\u2014revised report of an EFNS task force. Eur J Neurol 16(9):968\u2013981","journal-title":"Eur J Neurol"},{"issue":"4","key":"2790_CR7","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1016\/S0733-8619(18)30319-0","volume":"8","author":"KM Welch","year":"1990","unstructured":"Welch KM, D\u2019Andrea G, Tepley N, Barkley G, Ramadan NM (1990) The concept of migraine as a state of central neuronal hyperexcitability. Neurol Clin 8(4):817\u2013828","journal-title":"Neurol Clin"},{"issue":"1","key":"2790_CR8","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1526-4610.2008.01279.x","volume":"49","author":"G Apostol","year":"2009","unstructured":"Apostol G, Lewis DW, Laforet GA, Robieson WZ, Fugate JM, Abi-Saab WM et al (2009) Divalproex sodium extended-release for the prophylaxis of migraine headache in adolescents: results of a stand-alone, long-term open-label safety study. Headache. 49(1):45\u201353","journal-title":"Headache."},{"issue":"8","key":"2790_CR9","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1001\/jama.291.8.965","volume":"291","author":"JL Brandes","year":"2004","unstructured":"Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J et al (2004) Topiramate for migraine prevention: a randomized controlled trial. JAMA. 291(8):965\u2013973","journal-title":"JAMA."},{"issue":"1\u20132","key":"2790_CR10","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/S0304-3940(01)01884-5","volume":"306","author":"I Niespodziany","year":"2001","unstructured":"Niespodziany I, Klitgaard H, Margineanu DG (2001) Levetiracetam inhibits the high-voltage-activated Ca(2+) current in pyramidal neurones of rat hippocampal slices. Neurosci Lett 306(1\u20132):5\u20138","journal-title":"Neurosci Lett"},{"issue":"1","key":"2790_CR11","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1046\/j.1528-1157.2002.24501.x","volume":"43","author":"EA Lukyanetz","year":"2002","unstructured":"Lukyanetz EA, Shkryl VM, Kostyuk PG (2002) Selective blockade of N-type calcium channels by levetiracetam. Epilepsia. 43(1):9\u201318","journal-title":"Epilepsia."},{"issue":"2","key":"2790_CR12","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1358\/mf.2003.25.2.723686","volume":"25","author":"PN Patsalos","year":"2003","unstructured":"Patsalos PN (2003) The pharmacokinetic characteristics of levetiracetam. Methods Find Exp Clin Pharmacol 25(2):123\u2013129","journal-title":"Methods Find Exp Clin Pharmacol"},{"issue":"2","key":"2790_CR13","doi-asserted-by":"publisher","first-page":"159","DOI":"10.2165\/00023210-199707020-00006","volume":"7","author":"M Haria","year":"1997","unstructured":"Haria M, Balfour JA (1997) Levetiracetam. CNS Drugs 7(2):159\u2013164","journal-title":"CNS Drugs"},{"issue":"1","key":"2790_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.2174\/187152411794961086","volume":"11","author":"V Pizza","year":"2011","unstructured":"Pizza V, Busillo V, Agresta A, Bisogno A, Capasso A (2011) Elderly patients with migraine: an open-label study on prophylaxis therapy with levetiracetam. Cent Nerv Syst Agents Med Chem 11(1):31\u201334","journal-title":"Cent Nerv Syst Agents Med Chem"},{"issue":"6","key":"2790_CR15","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/WNF.0000000000000005","volume":"36","author":"A Verma","year":"2013","unstructured":"Verma A, Srivastava D, Kumar A, Singh V (2013) Levetiracetam in migraine prophylaxis: a randomized placebo-controlled study in a rural medical institute in northern India. Clin Neuropharmacol 36(6):193\u2013197","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"2790_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1517\/14728214.2012.709846","volume":"17","author":"L Lionetto","year":"2012","unstructured":"Lionetto L, Negro A, Palmisani S, Gentile G, Del Fiore MR, Mercieri M et al (2012) Emerging treatment for chronic migraine and refractory chronic migraine. Expert Opin Emerg Drugs 17(3):393\u2013406","journal-title":"Expert Opin Emerg Drugs"},{"issue":"6","key":"2790_CR17","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1097\/01.WNF.0000236766.08409.03","volume":"29","author":"F Brighina","year":"2006","unstructured":"Brighina F, Palermo A, Aloisio A, Francolini M, Giglia G, Fierro B (2006) Levetiracetam in the prophylaxis of migraine with aura: a 6-month open-label study. Clin Neuropharmacol 29(6):338\u2013342","journal-title":"Clin Neuropharmacol"},{"issue":"Suppl 2","key":"2790_CR18","doi-asserted-by":"publisher","first-page":"s111","DOI":"10.1007\/s10072-005-0422-9","volume":"26","author":"AM Rapoport","year":"2005","unstructured":"Rapoport AM, Bigal ME (2005) Migraine preventive therapy: current and emerging treatment options. Neurol Sci : Off J Italian Neurol Soc Italian Soc Clin Neurophysiol 26(Suppl 2):s111\u2013s120","journal-title":"Neurol Sci : Off J Italian Neurol Soc Italian Soc Clin Neurophysiol"},{"key":"2790_CR19","doi-asserted-by":"crossref","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JPA et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ (Clinical Research ed) 339:\u2013b2700","DOI":"10.1136\/bmj.b2700"},{"issue":"1","key":"2790_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","volume":"17","author":"AR Jadad","year":"1996","unstructured":"Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ et al (1996) Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17(1):1\u201312","journal-title":"Control Clin Trials"},{"key":"2790_CR21","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Clinical research ed). 2016;355:i4919","DOI":"10.1136\/bmj.i4919"},{"issue":"5","key":"2790_CR22","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","volume":"273","author":"KF Schulz","year":"1995","unstructured":"Schulz KF, Chalmers I, Hayes RJ, Altman DG (1995) Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. Jama. 273(5):408\u2013412","journal-title":"Jama."},{"issue":"2","key":"2790_CR23","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10194-003-0043-8","volume":"4","author":"V Gallai","year":"2003","unstructured":"Gallai V, Alberti A, Rossi C, Coppola F, Gallai B, Mazzotta G et al (2003) An open-label pilot study on the efficacy and tolerability of levetiracetam in the prophylaxis of migraine. J Headache Pain 4(2):92\u201396","journal-title":"J Headache Pain"},{"issue":"3","key":"2790_CR24","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1016\/j.curtheres.2005.06.006","volume":"66","author":"AM Rapoport","year":"2005","unstructured":"Rapoport AM, Sheftell FD, Tepper SJ, Bigal ME (2005) Levetiracetam in the preventive treatment of transformed migraine: A prospective, open-label, pilot study. Curr Therapeut Res Clin Experiment 66(3):212\u2013221","journal-title":"Curr Therapeut Res Clin Experiment"},{"issue":"9","key":"2790_CR25","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1016\/j.ejpain.2011.03.012","volume":"15","author":"F Brighina","year":"2011","unstructured":"Brighina F, Cosentino G, Vigneri S, Talamanca S, Palermo A, Giglia G et al (2011) Abnormal facilitatory mechanisms in motor cortex of migraine with aura. Eur J Pain (London, England) 15(9):928\u2013935","journal-title":"Eur J Pain (London, England)"},{"issue":"10","key":"2790_CR26","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1111\/j.1526-4610.2008.01292.x","volume":"48","author":"W Young","year":"2008","unstructured":"Young W, Shaw J, Bloom M, Gebeline-Myers C (2008) Correlation of increase in phosphene threshold with reduction of migraine frequency: observation of levetiracetam-treated subjects. Headache. 48(10):1490\u20131498","journal-title":"Headache."},{"issue":"2","key":"2790_CR27","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.neulet.2008.06.076","volume":"442","author":"M de Tommaso","year":"2008","unstructured":"de Tommaso M, Guido M, Sardaro M, Serpino C, Vecchio E, De Stefano G et al (2008) Effects of topiramate and levetiracetam vs placebo on habituation of contingent negative variation in migraine patients. Neurosci Lett 442(2):81\u201385","journal-title":"Neurosci Lett"},{"issue":"1","key":"2790_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2174\/1574884712666170329094419","volume":"12","author":"D Kashipazha","year":"2017","unstructured":"Kashipazha D, Ghadikolaei HS, Siavashi M (2017) Levetiracetam in Compare to Sodium Valproate for Prophylaxis in Chronic Migraine Headache: A Randomized Double-Blind Clinical Trial. Curr Clin Pharmacol 12(1):55\u201359","journal-title":"Curr Clin Pharmacol"},{"key":"2790_CR29","unstructured":"FDA (2018) FDA approves novel preventive treatment for migraine"},{"issue":"4","key":"2790_CR30","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s40265-019-01069-1","volume":"79","author":"S Lattanzi","year":"2019","unstructured":"Lattanzi S, Brigo F, Trinka E et al (2019) Erenumab for preventive treatment of migraine: a systematic review and meta-analysis of efficacy and safety. Drugs. 79(4):417\u2013431","journal-title":"Drugs."},{"key":"2790_CR31","doi-asserted-by":"crossref","unstructured":"Linde M, Mulleners WM, Chronicle EP, Mccrory DC (2013) Topiramate for the prophylaxis of episodic migraine in adults. The Cochrane database of systematic reviews. (6):Cd010610","DOI":"10.1002\/14651858.CD010610"},{"key":"2790_CR32","doi-asserted-by":"crossref","unstructured":"Linde M, Mulleners WM, Chronicle EP, McCrory DC 2013 Valproate (valproic acid or sodium valproate or a combination of the two) for the prophylaxis of episodic migraine in adults. The Cochrane database of systematic reviews. (6):Cd010611","DOI":"10.1002\/14651858.CD010611"},{"issue":"1","key":"2790_CR33","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0972-2327.144290","volume":"18","author":"H Sadeghian","year":"2015","unstructured":"Sadeghian H, Motiei-Langroudi R (2015) Comparison of Levetiracetam and sodium Valproate in migraine prophylaxis: A randomized placebo-controlled study. Ann Indian Acad Neurol 18(1):45\u201348","journal-title":"Ann Indian Acad Neurol"},{"key":"2790_CR34","unstructured":"EMA. New measures to avoid valproate exposure in pregnancy endorsed. 2018"},{"issue":"1","key":"2790_CR35","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s10194-017-0720-7","volume":"18","author":"A He","year":"2017","unstructured":"He A, Song D, Zhang L, Li C (2017) Unveiling the relative efficacy, safety and tolerability of prophylactic medications for migraine: pairwise and network-meta analysis. J Headache Pain 18(1):26","journal-title":"J Headache Pain"},{"issue":"1","key":"2790_CR36","first-page":"17","volume":"99","author":"H Ha","year":"2019","unstructured":"Ha H, Gonzalez A (2019) Migraine Headache Prophylaxis. Am Fam Physician 99(1):17\u201324","journal-title":"Am Fam Physician"},{"issue":"3","key":"2790_CR37","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1526-4610.2007.00728.x","volume":"47","author":"A Pakalnis","year":"2007","unstructured":"Pakalnis A, Kring D, Meier L (2007) Levetiracetam prophylaxis in pediatric migraine\u2014an open-label study. Headache. 47(3):427\u2013430","journal-title":"Headache."},{"issue":"3","key":"2790_CR38","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/j.1526-4610.2004.04053.x","volume":"44","author":"GS Miller","year":"2004","unstructured":"Miller GS (2004) Efficacy and Safety of Levetiracetam in Pediatric Migraine. Headache: J Head Face Pain 44(3):238\u2013243","journal-title":"Headache: J Head Face Pain"},{"issue":"4","key":"2790_CR39","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/jcpt.12715","volume":"43","author":"AK Watkins","year":"2018","unstructured":"Watkins AK, Gee ME, Brown JN (2018) Efficacy and safety of levetiracetam for migraine prophylaxis: A systematic review. J Clin Pharm Ther 43(4):467\u2013475","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"2790_CR40","first-page":"74","volume":"9","author":"Y Awaad","year":"2014","unstructured":"Awaad Y, Rizk T (2014) Levetiracetam in the treatment of pediatric headache. J Taibah Univ Med Sci 9(1):74\u201377","journal-title":"J Taibah Univ Med Sci"},{"issue":"21","key":"2790_CR41","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1001\/jamainternmed.2013.10391","volume":"173","author":"K Meissner","year":"2013","unstructured":"Meissner K, F\u00e4ssler M, R\u00fccker G et al (2013) Differential effectiveness of placebo treatments: A systematic review of migraine prophylaxis. JAMA Intern Med 173(21):1941\u20131951","journal-title":"JAMA Intern Med"},{"key":"2790_CR42","doi-asserted-by":"crossref","unstructured":"Jackson JL, Kuriyama A, Anton A, et al. (2019) The Accuracy of Google Translate for Abstracting Data From Non-English-Language Trials for Systematic Reviews. Ann Intern Med 30","DOI":"10.7326\/M19-0891"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-019-02790-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-019-02790-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,27]],"date-time":"2024-07-27T18:21:02Z","timestamp":1722104462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-019-02790-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,25]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["2790"],"URL":"https:\/\/doi.org\/10.1007\/s00228-019-02790-2","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"type":"print","value":"0031-6970"},{"type":"electronic","value":"1432-1041"}],"subject":[],"published":{"date-parts":[[2019,11,25]]},"assertion":[{"value":"23 September 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}